| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $163.5M | — | +22.3% |
| Cost of Revenue | $185.1M | — | -10.8% |
| Gross Profit | -$21.6M | — | +70.7% |
| R&D Expense | $12.1M | — | -30.2% |
| SG&A Expense | $70.2M | — | -13.2% |
| Operating Income | -$109.5M | — | +38.6% |
| Interest Expense | $17.4M | — | +51.1% |
| Pre-tax Income | -$246.0M | — | -25.0% |
| Income Tax | $41K | — | — |
| Net Income | -$245.3M | — | -24.7% |
| EPS (Basic) | -$0.18 | — | +14.3% |
| EPS (Diluted) | -$0.18 | — | +14.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $223.2M | -39.4% | -24.6% |
| Accounts Receivable | $106.5M | -21.0% | -26.5% |
| Inventory | $516.2M | -0.9% | -25.6% |
| Current Assets | $1.27B | -9.6% | -16.9% |
| Total Assets | $2.37B | -8.7% | -34.8% |
| Current Liabilities | $540.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$150.0M | — | -42.1% |
| Capital Expenditures | $2.4M | — | -94.0% |
| Investing Cash Flow | -$8.5M | — | +81.8% |
| Financing Cash Flow | -$31.7M | — | -116.4% |
| Free Cash Flow | -$152.4M | — | -4.4% |
| -31.4% |
| Total Liabilities | $1.59B | +0.2% | -6.3% |
| Stockholders' Equity | $749.8M | -23.3% | -59.6% |